Target intelligence / Profile preview

Reactive oxygen species and biomolecular double bonds

Molecular classification
Other
01

Overview

Reactive oxygen species and biomolecular double bonds refers to the chemical interaction where reactive oxygen species (ROS), such as hydroxyl radicals or singlet oxygen, attack unsaturated carbon-carbon bonds in lipids, proteins, and nucleic acids [1, 2]. This process is most prominently observed in lipid peroxidation, where ROS initiate a chain reaction in polyunsaturated fatty acids within cell membranes, leading to the degradation of membrane integrity [1, 3]. The resulting formation of reactive aldehydes like malondialdehyde can further damage cellular components and interfere with normal function [1]. While ROS are essential at low concentrations for physiological signaling and immune defense, their uncontrolled reaction with biomolecular double bonds is a hallmark of oxidative stress [2, 4]. This oxidative damage is a key pathological driver in various conditions, including cardiovascular disease, neurodegeneration, and cancer [3]. Therapeutic strategies targeting this interaction typically involve the use of antioxidants and radical scavengers to neutralize ROS before they can cause irreversible damage to vital biomolecular structures [2, 3].

Other names
Lipid peroxidationOxidative damageROS-mediated oxidationOxidative stress-induced damage
02

Mechanism of action

Antioxidants and radical scavengers act by donating electrons or hydrogen atoms to neutralize reactive oxygen species, thereby preventing the initiation and propagation of oxidative damage to biomolecular double bonds [2, 3].

03

Biological functions

Oxidative stressCell signalingApoptosisLipid peroxidationImmune response
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationAging
05

Safety considerations

Reductive stressInterference with physiological ROS signalingPotential pro-oxidant activity at high dosesImpairment of immune-mediated pathogen clearance
06

Interacting drugs

N-acetylcysteine

4 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)4-Hydroxynonenal (4-HNE)8-Isoprostane (8-iso-PGF2α)Protein carbonyls8-Hydroxy-2-deoxyguanosine (8-OHdG)

Beyond the preview

Go deeper on Reactive oxygen species and biomolecular double bonds.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species and biomolecular double bonds.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call